PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New Huntington’s treatment prevents protein aggregation

Designer polymers disrupt protein interactions to preserve cell health in mouse study

New Huntington’s treatment prevents protein aggregation
2024-11-01
(Press-News.org)

Scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington’s disease, an incurable, debilitating illness that causes nerve cells to break down in the brain.

Patients with Huntington’s disease have a genetic mutation that triggers proteins to misfold and clump together in the brain. These clumps interfere with cell function and eventually lead to cell death. As the disease progresses, patients lose the ability to talk, walk, swallow and concentrate. Most patients die within 10 to 20 years after symptoms first appear.

The new treatment leverages peptide-brush polymers, which act as a shield to prevent proteins from binding to one another. In studies in mice, the treatment successfully rescued neurons to reverse symptoms. The treated mice also experienced no significant side effects, confirming the therapy is nontoxic and well tolerated.

Although the treatment needs further testing, the researchers imagine it potentially someday could be administered as a once-weekly injection to delay disease onset or reduce symptoms in patients with the genetic mutation.

The study will be published on Friday (Nov. 1), in the journal Science Advances.

“Huntington’s is a horrific, insidious disease,” said Northwestern’s Nathan Gianneschi, who led the polymer therapeutic development. “If you have this genetic mutation, you will get Huntington’s disease. It’s unavoidable; there’s no way out. There is no real treatment for stopping or reversing the disease, and there is no cure. These patients really need help. So, we started thinking about a new way to address this disease. The misfolded proteins interact and aggregate. We’ve developed a polymer that can fight those interactions.”

Gianneschi is the Jacob and Rosaline Cohn Professor of Chemistry at Northwestern’s Weinberg College of Arts and Sciences and professor of materials science and engineering and biomedical engineering at Northwestern’s McCormick School of Engineering as well as in Pharmacology at Feinberg School of Medicine. He also is a member of the International Institute of Nanotechnology. Gianneschi co-led the study with Xin Qi, the Jeanette M. and Joseph S. Silber Professor of Brain Sciences and co-director of the Center for Mitochondrial Research and Therapeutics, at Case Western Reserve University.

Promising peptide

The new study builds on previous work from Qi’s laboratory at Case Western Reserve. In 2016, Qi and her team identified a protein (valosin-containing protein or VCP) that abnormally binds to the mutant Huntington protein, causing protein aggregates. These aggregates accumulate within a cell’s mitochondria, an organelle that generates the energy needed to power a cell’s biochemical reactions. Without functioning mitochondria, the cells become dysfunctional and then self-destruct. 

As part of that study, Qi also uncovered a naturally occurring peptide that disrupts the interaction between the VCP and the mutant Huntington protein. In cells exposed to the peptide, both the VCP and mutant Huntington protein bound to the peptide — instead of each other.

“Qi’s team identified a peptide that comes from the mutant protein itself and basically controls the protein-protein interface,” Gianneschi said. “That peptide inhibited mitochondrial death, so it showed promise.”

Pulling apart proteins like Velcro

But the peptide, by itself, faced several limitations. Because they are easily broken down by enzymes, peptides have a short lifespan in the body and often have difficulty effectively entering cells. For the peptide to inhibit Huntington’s disease, it needs to cross the blood-brain barrier in large enough quantities to prevent large-scale protein aggregation. 

“The peptide has a very small footprint with respect to the protein interfaces,” Gianneschi said. “The proteins stick to each other like Velcro. In this analogy, one protein has hooks and the other has loops. The peptide, on its own, is like trying to undo a patch of Velcro by pulling apart one hook and loop at a time. By the time you get to the bottom of the patch, the top has already come back together and resealed. We needed something big enough to disrupt the entire interface.”

To overcome these obstacles, Gianneschi and his team developed a biocompatible polymer that displays multiple copies of the active peptide. The new structure has a polymer backbone with peptides attached like branches. Not only does the structure protect the peptides from destructive enzymes, it also helps them cross the blood-brain barrier and enter cells.

Experimental results

In laboratory experiments, Gianneschi and his team injected the protein-like polymer into a mouse model of Huntington’s disease. The polymers stayed in the body 2,000 times longer than traditional peptides. In biochemical and neuropathological examinations, the researchers found the treatment prevented mitochondrial fragmentation to preserve the health of brain cells. According to Gianneschi, the mice with Huntington’s disease also lived longer and behaved more like normal mice.

“In one study, the mice are examined in an open field test,” Gianneschi said. “In the animals with Huntington’s, as the disease progresses, they stay along the edges of the box. Whereas normal animals cross back and forth to explore the space. The treated animals with Huntington’s disease started to do the same thing. It’s quite compelling when you see animals behave more normally than they would otherwise.”

Next, Gianneschi will continue to optimize the polymer, with plans to explore its use in other neurodegenerative diseases.

“My childhood friend was diagnosed with Huntington’s at age 18 through a genetic test,” Gianneschi said. “He’s now in an assisted living facility because he needs 24-hour, full-time care. I remain highly motivated — both personally and scientifically — to continue traveling down the path.”

The study, “Proteomimetic polymer blocks mitochondrial damage, rescues Huntington’s neurons and slows onset of neuropathy in vivo,” was supported by the International Institute of Nanotechnology Convergence Science Medicine Institute grant, National Institutes of Health (award numbers 1F31AG076334, R01AG065240, R01NS115903, R01AG076051 and RF1AG074346.)

END


[Attachments] See images for this press release:
New Huntington’s treatment prevents protein aggregation New Huntington’s treatment prevents protein aggregation 2

ELSE PRESS RELEASES FROM THIS DATE:

Bee gene specifies collective behavior

Bee gene specifies collective behavior
2024-11-01
Embargoed: Not for Release Until 2:00 pm U.S. Eastern Time Friday, 01 November 2024. Researchers at Heinrich Heine University Düsseldorf (HHU) are collaborating with colleagues from Frankfurt/Main, Oxford and Würzburg to investigate how the complex, cooperative behaviour of honey bees (Apis mellifera) is genetically programmed so that it can be passed on to subsequent generations. As they explain in the scientific journal Science Advances, they found an answer in what is known as the doublesex gene (dsx). Behavioural interactions between organisms are fundamental and often inherited. ...

Jennifer Bickel, M.D., named MD Anderson Vice President and Chief Wellness Officer

Jennifer Bickel, M.D., named MD Anderson Vice President and Chief Wellness Officer
2024-11-01
HOUSTON ― The University of Texas MD Anderson Cancer Center today announced the selection of Jennifer Bickel, M.D., as the institution’s inaugural vice president and chief wellness officer (CWO). She will begin on January 6, 2025. Working closely with the senior vice president of people, culture and infrastructure, as well as the chief academic officer, she will spearhead initiatives that prioritize employee well-being, professional fulfillment and community resilience.  In her new role, Bickel will implement a three-component model focusing on a culture of wellness, efficiency ...

Evolutionary paths vastly differ for birds, bats

2024-11-01
ITHACA, N.Y. – New Cornell University research has found that, unlike birds, the evolution of bats’ wings and legs is tightly coupled, which may have prevented them from filling as many ecological niches as birds. “We initially expected to confirm that bat evolution is similar to that of birds, and that their wings and legs evolve independently of one another. The fact we found the opposite was greatly surprising,” said Andrew Orkney, postdoctoral researcher in the laboratory of Brandon Hedrick, assistant professor biomedical sciences. Both researchers ...

Political pros no better than public in predicting which messages persuade

2024-11-01
Political campaigns spend big bucks hiring consultants to craft persuasive messaging, but a new study coauthored by Yale political scientist Joshua L. Kalla demonstrates that political professionals perform no better than laypeople in predicting which messages will sway voters. In the study, Kalla and his coauthors evaluated how well sample groups of political practitioners — professionals who work for political campaigns, polling firms, and advocacy organizations — and members of the public could predict the effectiveness of 172 campaign messages concerning 21 political issues, including legalizing marijuana, cancelling student debt, and increasing ...

Investment in pediatric emergency care could save more than 2,100 young lives annually

2024-11-01
In emergencies, children have distinct needs because of their unique physiological, emotional and developmental characteristics. But 83% of emergency departments nationwide are not fully prepared to meet those needs — which can be life-threatening for a child in cases of severe illness or injury. A new Oregon Health & Science University-led study, published today in JAMA Network Open, found that bridging that gap, known as becoming “pediatric ready,” could prevent the deaths of more than 2,100 children each year with modest financial investment. ...

The dynamic core of black holes

2024-11-01
Black holes continue to captivate scientists: they are purely gravitational objects, remarkably simple, yet capable of hiding mysteries that challenge our understanding of natural laws. Most observations thus far have focused on their external characteristics and surrounding environment, leaving their internal nature largely unexplored. A new study, conducted through a collaboration between the University of Southern Denmark, Charles University in Prague, Scuola Internazionale Superiore di Studi Avanzati (SISSA) in Trieste, and Victoria University of Wellington ...

Improving energy production by boosting singlet fission process

Improving energy production by boosting singlet fission process
2024-11-01
Fukuoka, Japan—In organic molecules an exciton is a particle bound pair of an electron (negative charge) and its hole (positive charge). They are held together by Coulombic attraction and can move within molecular assemblies. Singlet fission (SF) is a process where an exciton is amplified, and two triplet excitons are generated from a singlet exciton. This is caused by the absorption of a single particle of light, or photon, in molecules called chromophores (molecules that absorb specific wavelengths of light). Controlling the molecular orientation and arrangement of chromophores is crucial for achieving high SF efficiency in materials with strong potential for optical ...

Smoking cessation and incident cardiovascular disease

2024-11-01
About The Study: In this cohort study, smoking and cardiovascular disease (CVD) risk exhibited a dose-dependent association, with light ex-smokers having a CVD risk similar to that of never-smokers relatively soon after smoking cessation. For heavy ex-smokers, greater than 25 years might be required for the residual CVD risk to align with that of never-smokers.  Corresponding Author: To contact the corresponding author, Seung Yong Shin, MD, PhD, email theshin04@korea.ac.kr. To access the embargoed study: Visit our For ...

Cannabis use during early pregnancy following recreational cannabis legalization

2024-11-01
About The Study: In this time-series study, recreational cannabis legalization implementation in California was associated with an increase in rates of cannabis use during early pregnancy, defined by both self-report and toxicology testing, driven by individuals living in jurisdictions that allowed adult-use retailers. Corresponding Author: To contact the corresponding author, Kelly C. Young-Wolff, PhD, MPH, email kelly.c.young-wolff@kp.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamahealthforum.2024.3656) Editor’s Note: Please see the article ...

Research shows Cleveland Clinic’s therapeutic virtual yoga program can be effective for chronic low back pain

2024-11-01
Research Shows Cleveland Clinic’s Therapeutic Virtual Yoga Program Can Be Effective for Chronic Low Back Pain  Participants also reported better sleep quality and reduced use of pain medications   UNDER EMBARGO Friday, November 01, 2024, 11:00 a.m. ET, CLEVELAND: Cleveland Clinic researchers found that a 12-week therapeutic virtual yoga program for chronic low back pain can be a feasible, safe and effective treatment option. The findings are published in JAMA Network Open.   Chronic low back pain is very common — up to 20% of adults worldwide have long-lasting or recurrent lower back pain. In severe cases, ...

LAST 30 PRESS RELEASES:

The distinct nerve wiring of human memory

Researchers discover new third class of magnetism that could transform digital devices

Personalized blood count could lead to early intervention for common diseases

Innovative tissue engineering: Boston University's ESCAPE method explained

Global healthspan-lifespan gaps among 183 WHO member states

Stanford scientists transform ubiquitous skin bacterium into a topical vaccine

Biological diversity is not just the result of genes

Analysis reveals an additional mechanism behind statin therapy’s heart-related benefits in people with HIV

Understanding how the immune system switches between rest and action

Wiley expands its KnowItAll solutions with new tools for LC-MS analysis, enterprise data management, and additional spectral advances

A new class of antivirals could help prevent future pandemics

Nature Biotechnology | Generative chemistry enables Insilico to develop gut-restricted PhD inhibitors promising for intestinal mucosal barrier repair and immunomodulation

2 U-M faculty members elected to National Academy of Inventors

Breakthroughs in cell-penetrating monoclonal antibody therapies

Accelerated aging in young sickle cell patients linked to elevated T-cell p16INK4a

Nanofluidic devices redefining matter manipulation at an unprecedented level

Powering the future together – Public-Private Collaboration for the energy transition in Finland

Exosome-mediated crosstalk in the tumor immune microenvironment: Critical drivers of hepatocellular carcinoma progression

JMIR Aging achieves top ranking, accepted into prestigious science citation indexes

Persistent tobacco smoking from childhood may cause heart damage by the mid-twenties

Smoking tobacco from childhood can cause premature heart damage

Southwest Research Institute seeks contractors worldwide to support Oil Sampling Program

Statistical and engineering approaches to federated learning: Comprehensive benchmarking for healthcare applications

AI can help us choose words more carefully when talking about addiction

Religious people are not more generous – with one exception

PARP inhibition shows long-term survival benefits for patients with high-risk, BRCA-positive breast cancer in OlympiA trial

BRCA-mutation carriers with a history of early-onset breast cancer may benefit from risk-reducing surgery

Next-generation SERD protects against progression in some patients with advanced breast cancer resistant to standard hormone therapy

Carnegie Mellon University Africa and Challenger Center collaborate to deliver STEM programs

Top five rising star Texas researchers named in 2025 Edith and Peter O’Donnell Awards by TAMEST

[Press-News.org] New Huntington’s treatment prevents protein aggregation
Designer polymers disrupt protein interactions to preserve cell health in mouse study